Login to Your Account



Point Therapeutics Offering Gets $22.2M For Talabostat

By Randall Osborne


Wednesday, November 23, 2005
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription